Joanne Wuensch (Citi) — Analyst Ratings, Accuracy & Track Record

Q: How accurate are Joanne Wuensch's stock ratings?

About 59% of Joanne's ratings were profitable over a one-year hold, with an average return of +4.3% per rating, measured by 13Foresight from historical prices.

Q: How is Joanne ranked?

Joanne Wuensch is ranked #657 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Analyst Tracker/Joanne Wuensch

Citi

Joanne Wuensch

Citi

Wall Street Analyst

★★★★☆

#657

on 13Foresight · ranked by our own returns

59%

Success Rate

+4.3%

Average Return

38 of 64 calls profitable · +1.9% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compare To ⓘ

🔒 5-year track record is Pro. Showing 1-year — upgrade.

📈 Across the calls we could measure, roughly 59% of Joanne Wuensch's ratings turned a profit when each position was held for 1 year — averaging +4.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

155 Buy 89 Hold 9 Sell

Joanne's Stock Coverage 29 ratings · 2026-07-13

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return
MMED MiniMed Group, Inc.	Jul 08, 2026	BUY	Strong Buy +41.7% avg upside 13 analysts	$23.00 50.35% Upside	·
ISRG Intuitive Surgical	Jul 08, 2026	BUY	Strong Buy +30.3% avg upside 36 analysts	$590.00 45.13% Upside	-2.0%
JNJ Johnson & Johnson	Jul 08, 2026	BUY	Strong Buy -13.9% avg upside 36 analysts	$298.00 15.94% Upside	-2.4%
SYK Stryker	Jul 08, 2026	BUY	Strong Buy +14.5% avg upside 37 analysts	$385.00 16.68% Upside	+0.9%
ZBH Zimmer Biomet Holdings	Jul 08, 2026	HOLD	Buy +21.9% avg upside 38 analysts	$93.00 1.87% Upside	+4.3%
TNDM Tandem Diabetes Care	Jul 08, 2026	HOLD	Buy +114.4% avg upside 29 analysts	$17.00 10.35% Upside	·
GKOS Glaukos	Jul 08, 2026	BUY	Strong Buy -8.0% avg upside 21 analysts	$175.00 14.68% Upside	+0.0%
PEN Penumbra	Jul 08, 2026	HOLD	Buy +3.9% avg upside 23 analysts	$350.00 10.13% Upside	+0.3%
IRTC Irhythm Technologies	Jul 08, 2026	BUY	Strong Buy +44.9% avg upside 19 analysts	$157.00 35.16% Upside	-7.3%
SGHT Sight Sciences	Jul 08, 2026	HOLD	Buy +53.5% avg upside 13 analysts	$6.00 12.77% Upside	·
BLCO Bausch + Lomb Corporation	Jul 08, 2026	BUY	Buy +20.9% avg upside 19 analysts	$21.00 29.32% Upside	+0.0%
GEHC GE Healthcare Technologies Inc	Jul 08, 2026	HOLD	Buy +27.0% avg upside 22 analysts	$69.00 6.69% Upside	+0.0%
COO Cooper Co	Jul 08, 2026	HOLD	Buy +89.2% avg upside 21 analysts	$76.00 7.59% Upside	·
EW Edwards Lifesciences	Jul 08, 2026	BUY	Strong Buy +6.7% avg upside 34 analysts	$110.00 19.28% Upside	-2.8%
ITGR Integer Holdings	Jul 08, 2026	HOLD	Buy +3.2% avg upside 15 analysts	$96.00 2.53% Upside	·
HAE Haemonetics	Jul 08, 2026	HOLD	Buy -10.7% avg upside 17 analysts	$79.00 3.77% Upside	+1.6%
PODD Insulet	Jul 08, 2026	HOLD	Strong Buy +61.0% avg upside 32 analysts	$172.00 6.56% Upside	+2.4%
IART Integra Lifesciences	Jul 08, 2026	HOLD	Buy +124.6% avg upside 21 analysts	$19.00 1.10% Upside	·
MDT Medtronic	Jul 06, 2026	BUY	Buy +15.5% avg upside 38 analysts	$110.00 31.20% Upside	+0.9%
DXCM Dexcom	Jul 06, 2026	BUY	Strong Buy +33.9% avg upside 32 analysts	$84.00 12.03% Upside	+3.6%
ESTA Establishment Labs Holdings	Jul 06, 2026	HOLD	Strong Buy -3.6% avg upside 12 analysts	$92.00 4.61% Upside	-3.9%
ABT Abbott Laboratories	Jul 06, 2026	BUY	Strong Buy +24.2% avg upside 36 analysts	$108.00 14.92% Upside	-1.8%
BAX Baxter International	Jul 06, 2026	SELL	Hold +32.1% avg upside 23 analysts	$17.00 24.84% Downside	-0.2%
BDX Becton Dickinson	Jul 06, 2026	BUY	Buy +28.4% avg upside 25 analysts	$198.00 30.23% Upside	-2.3%
BSX Boston Scientific	Jul 06, 2026	BUY	Strong Buy +69.5% avg upside 38 analysts	$70.00 56.34% Upside	+0.4%
LUNG Pulmonx	May 23, 2025	HOLD	Buy +250.3% avg upside 9 analysts	$4.15 169.52% Upside	-50.2%
CH:ALC Alcon	Nov 16, 2022	HOLD	Buy +30.5% avg upside 35 analysts	$55.78 2.55% Upside	·
RMD Resmed	Jan 27, 2019	BUY	Buy +14.2% avg upside 27 analysts	$120.00 41.05% Downside	+77.7%
PFE Pfizer	Sep 26, 2016	BUY	Buy +39.1% avg upside 45 analysts	$40.00 65.58% Upside	+9.2%

🔒 24 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Joanne Wuensch — Frequently Asked Questions

How accurate are Joanne Wuensch's stock ratings?

Based on the calls 13Foresight could measure, about 59% of Joanne's ratings were profitable over a one-year hold, with an average return of +4.3% per rating, or +1.8% versus the S&P 500. We score every analyst the same way, from historical prices.

How is Joanne ranked on 13Foresight?

Joanne Wuensch is currently ranked #657 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Joanne cover?

Joanne most recently has ratings on MMED, ISRG, JNJ, SYK, ZBH, TNDM, GKOS, PEN, IRTC, SGHT, BLCO, GEHC and 17 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rating Distribution

Welcome to 13Foresight!